title: Substance abuse in adolescents: a complex conundrum for the clinician.
abstract: Substance abuse remains a complex and pervasive conundrum for society and for clinicians seeking to improve the lives of their pediatric patients. Substance abuse is linked to the human instinct for pleasure at any cost and is fueled by enticing encouragement of the media teaching society to seek drug-induced pleasure without fear of negative consequences. Other complications are the limited education about psychoactive substances provided to youth and the health care profession pledged to serve them. Primary care clinicians must provide their adolescent patients with adequate screening and counseling about substance abuse. Treatment of the substance-abusing patient is often a combination of behavioral interventions (including family therapy), and, in limited situations, addiction-specific medications. Research suggests that female drug addicts have a better outcome in female-only drug treatment programs. In addition, new drugs are being developed that target specific brain mechanisms involved in drug addiction; these drugs will have less toxicity and less abuse potential than illicit drugs such as cocaine. Vaccines are being developed that will block the effects of such drugs as cocaine and PCP. Medications developed for the treatment of depression and epilepsy will be a source of medications for the treatment of drug addiction. The study of endorphins and the neurobiology of stress and substance abuse promise to develop potent anti-addiction chemicals, greatly aiding in the war on drug abuse.
authors.affiliation: Department of Pediatrics and Human Development, Michigan State University College of Human Medicine, A 110 East Fee Hall, East Lansing, MI 48824, USA. Greydanus@kcms.msu.edu
authors.forename: Donald E
authors.initials: DE
authors.lastname: Greydanus
authors.forename: Dilip R
authors.initials: DR
authors.lastname: Patel
mesh_terms: D000293:Adolescent; D005260:Female; D006801:Humans; D008297:Male; D010818:Practice Patterns, Physicians'; D019966:Substance-Related Disorders / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D014481:United States / Q000453:epidemiology